The role of toll-like receptor 9 (TLR9) in Epstein-Barr virus-associated gastric cancer

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre, LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.10.3322/caac.2149230207593Search in Google Scholar

2. Didkowska J, Wojciechowska U, Olasek P. Cancer in Poland in 2015. Warszawa: Centrum Onkologii Instytut im. M. Skłodowskiej-Curie; 2017.Search in Google Scholar

3. Reza MA, Reza MH, Mehdieyeh L, Mehdi F, Hamid ZN. Evolution frequency of Merkel cell polyoma, Epstein-Barr and Mouse mammary tumor viruses in patients with Brest cancer in Kerman Southeast of Iran. Asian Pac J Cancer Prev. 2015;16(16):7351-7.10.7314/APJCP.2015.16.16.735126514536Search in Google Scholar

4. Chen XZ, Che H, Castro FH, Hu J, Brenner H. Epstein-Barr virus infection and gastric cancer: a systematic review. Medicine. 2015; 94(20):e792.10.1097/MD.0000000000000792460288725997049Search in Google Scholar

5. IARC monographs on the evaluation of carcinogenic risks to humans. A review of human carcinogens. Biological agents. Lyon: International Agency for Research on Cancer; 2012.Search in Google Scholar

6. Liu S, Zhao Z, Han L, Liu S, Luo B. Epstein-Barr Virus Infection in Gastric Remnant Carcinoma and Recurrent Gastric Carcinoma in Qingdao of Northern China. PloSOne. 2016;11(2):e0148342.10.1371/journal.pone.0148342474750926859565Search in Google Scholar

7. Chen CJ, Hsu WL, Yang HI, Lee MH, Chen HC, Chien YC, You SL. Epidemiology of virus infection and human cancer. Recent Results Cancer Res. 2014;193:11-32.10.1007/978-3-642-38965-8_224008291Search in Google Scholar

8. zur Hausen A, Brink AA, Craanen ME, Middeldorp JM, Meijer CJ, van den Brule AJ. Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. Cancer Res. 2000;60(10):2745-8.10.1016/S0016-5085(00)82313-6Search in Google Scholar

9. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517): 202-9.10.1038/nature13480417021925079317Search in Google Scholar

10. Cho J, Kang M, Kim KM. Epstein-Barr virus associated gastric carcinoma and specific features of the accompanying immune response. J Gastric Cancer. 2016;16(1):1-7.10.5230/jgc.2016.16.1.1483461527104020Search in Google Scholar

11. Loganathan R, Nazeer M, Goda V, Devaraju P, Ali M, Karunakaran P, Jayaraman M. Genetic variants of TLR4 and TLR9 are risk factors for chronic Helicobacter pylori infection in South Indian tamils. Hum Immunol. 2017;78(2):216-20.10.1016/j.humimm.2016.12.00227993530Search in Google Scholar

12. Bowie AG, Haga IR. The role of Toll-like receptors in the host response to viruses. Mol Immunol. 2005;42(8):859-67.10.1016/j.molimm.2004.11.00715829275Search in Google Scholar

13. Lime WH, Kireta S, Russ R, Coates PT. Human plasmacytoid dendritic cells regulate immune responses to Epstein-Barr virus (EBV) infection and delay EBV-related mortality in humanized NOD-SCID mice. Blood. 2007;109(3):1043-50.10.1182/blood-2005-12-02480217018863Search in Google Scholar

14. Pachnia D, Drop B, Dworzańska A, Kliszczewska E, Polz-Dacewicz M. Transforming Growth Factor-β, Interleukin-10, and Serological Markers in EBV-associated Gastric Carcinoma. Anticancer Res. 2017;37(9):4853-8.10.21873/anticanres.11893Search in Google Scholar

15. Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. Gastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow up. Eur J Surg Oncol. 2014;40(5):584-91.10.1016/j.ejso.2013.09.02024685156Search in Google Scholar

16. Hu B, El Hajj NE, Sittler S, Lammert N, Barnes R, Meloni-Ehrig A. Gastric cancer: Classification, histology and application of molecular pathology. J Gastrointest Oncol. 2012;3(3):251-61.Search in Google Scholar

17. Fołtyn S, Strycharz-Dudziak M, Drop B, Boguszewska A, Polz-Dacewicz M. Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer. Infect Agent Cancer. 2017;12:31.10.1186/s13027-017-0141-x545038928572837Search in Google Scholar

18. Rickinson AB. Co-infections, inflammation and oncogenesis: future directions for EBV research. Semin Cancer Biol. 2014;26:99-115.10.1016/j.semcancer.2014.04.00424751797Search in Google Scholar

19. Shcheblyakov DV, Logunov DY, Tukhvatulin AI, Shmarov MM, Naroditsky BS, Gintsburg AL. Toll-Like Receptors (TLRs): The Role in Tumor Progression. Acta Naturae. 2010;2(3):21-9.10.32607/20758251-2010-2-3-21-29Search in Google Scholar

20. Severa M, Giacomini E, Gafa V, Anastasiadou E, Rizzo F, Corazzari M, et al. EBV stimulates TLR- and autophagy – dependent patways and impairs maturation in plasmacytoid dendritic cells: Implications for viral immune escape. Eur J Immunol. 2013;43(1):147-58.10.1002/eji.20124255222996354Search in Google Scholar

21. Ngan RK, Lan WH, Yip TT, Cho WC, Cheng WW, Lim CK, et al. Remerkableaplication of serum EBV EBER-1 in monitoring response of nasopharyngeal cancer patients to salvage chemotherapy. Ann NY Acad Sci. 2001;995:73-9.10.1111/j.1749-6632.2001.tb03866.xSearch in Google Scholar

22. Căinap SS, Fetică B, Buiga R, Căinap C, Constantin AM, Şovrea AS. The prognostic role of EBER in pediatric cancer. Rom J Morphol Embroyol. 2015;56(4):1261-77.Search in Google Scholar

23. Sairenji T, Tajima M, Kanamori M, Takasaka N, Gao X, Murakami M, et al. Characterization of EBV-infected epithelial cells lines from gastric cancer-bearing tissues. Curr Top Microbiol Immunol. 2001; 258:185-98.10.1007/978-3-642-56515-1_1211443862Search in Google Scholar

24. Schetter A, You W, Lennette E, Goil M, Rabkin Ch. Association of Epstein-Barr virus antibody levels with precancerous gastric lesions in high-risk kohort. Cancer Sci. 2008;99(2):350-4.10.1111/j.1349-7006.2007.00668.x18201267Search in Google Scholar

25. Talar B, Czyż M. TGF-β signaling pathways in cancer. Postepy Hig Med Dosw (Online). 2013;25:1008-17.10.5604/17322693.106807324088545Search in Google Scholar

26. Chao Y, Jing Y, Jia Y, Wang Y, Zhao C, Luo B. Conservation and mutation of viral interleukin-10 gene in gastric carcinomas and nasopharyngeal carcinomas. J Med Virol. 2011;83(4):644-50.10.1002/jmv.2209121328379Search in Google Scholar

27. McKenzie J, Lopez-Giraldez F, Delecluse HJ, Walsh A, El-Guindy A. The Epstein-Barr virus immunoevasins BCRF1 and BPLF1 are expressed by a mechanism independent of the canonical late preinitiation complex. PLOS Pathogens. 2016;12(11):e1006008.10.1371/journal.ppat.1006008511399427855219Search in Google Scholar

28. Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev. 2008;226:205-18.10.1111/j.1600-065X.2008.00706.x272498219161426Search in Google Scholar

29. Ng TH, Britton GJ, Hill EV, Verhagen J, Burton BR, Wraith DC. Regulation of adaptive immunity; the role of interleukin-10. Front Immunol. 2013;4:129.10.3389/fimmu.2013.00129Search in Google Scholar

30. Khan AA, Khan Z, Warnakulasuriya S. Cancer-associated toll-like receptor modulation and insinuation in infection susceptibility: association or coincidence? Ann Oncol. 2016;27(6):984-97.10.1093/annonc/mdw05326861598Search in Google Scholar

31. Liu S, Wang X, Han L, Zhao Z, Zhao Ch, Luo B. Toll-like receptor gene polymorphisms and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma in Northern China. Saudi J Gastroenterol. 2015;21:95-103.10.4103/1319-3767.153832439258225843196Search in Google Scholar

32. Fernandez-Garcia B1, Eiró N, González-Reyes S, González L, Aguirre A, González LO, et al. Clinical significance of Toll-like receptor 3, 4, and 9 in gastric cancer. J Immunother. 2014;37(2):77-83.10.1097/CJI.000000000000001624509170Search in Google Scholar

33. Kayamba V, Monze M, Asombang AW, Zyambo K, Kelly P. Serological response to Epstein-Barr virus Elaryantygen is associated with gastric cancer and human immunodeficiency virus infection in Zambian adults: a case control study. Pan Afr Med J. 2016;23:1-5.10.11604/pamj.2016.23.45.8503486278527217871Search in Google Scholar

34. Nishikawa J, Iizasa H, Yoshiyama H, Nakamura M, Saito M, Sasaki S, et al. The role of epigenetic regulations in Epstein-Barr virus-associated gastric cancer. Int J Mol Sci. 2017;18(8):E1606.10.3390/ijms18081606557799828757548Search in Google Scholar